Essity Shares Fall After UBS Downgrade to 'Sell'

Shares of Essity AB (ESSITYa) declined in Tuesday trading after analysts at UBS downgraded the Swedish hygiene and health products company to a 'Sell' rating, triggering a wave of investor concern.

The bank's bearish call was accompanied by a new price target of SEK 235, a level significantly below the stock's recent trading range. The downgrade was the primary catalyst for the session's sell-off, which saw shares fall 1.1% to SEK 272.

Downgrade Amplifies Existing Headwinds

The negative revision from UBS comes against a backdrop of weakening financial performance for Essity. The company's most recent quarterly report showed an 11% year-over-year contraction in EBITA and a 12% decline in net income, results that had already prompted other analysts to trim their price targets.

Management has previously flagged a challenging input cost environment as an ongoing headwind, and Tuesday's downgrade reinforces investor concerns about the company's near-term earnings trajectory and ability to protect its profit margins.

Ad

Market Reaction and Context

Essity's decline stood in contrast to the broader market, as Sweden's benchmark OMXS30 index was trading modestly higher. This divergence indicates the selling pressure was specific to Essity rather than a reflection of a wider market downturn.

With the stock now trading closer to the lower end of its 52-week range of SEK 237–292.5, investors appear to be reassessing the company's valuation. The UBS price target suggests the bank sees a considerable risk of further downside from current levels.